BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 22253531)

  • 1. Protective role of cytotoxic T lymphocytes in filovirus hemorrhagic fever.
    Warfield KL; Olinger GG
    J Biomed Biotechnol; 2011; 2011():984241. PubMed ID: 22253531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ebola and Marburg virus vaccines.
    Reynolds P; Marzi A
    Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
    Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
    J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.
    Callendret B; Vellinga J; Wunderlich K; Rodriguez A; Steigerwald R; Dirmeier U; Cheminay C; Volkmann A; Brasel T; Carrion R; Giavedoni LD; Patterson JL; Mire CE; Geisbert TW; Hooper JW; Weijtens M; Hartkoorn-Pasma J; Custers J; Grazia Pau M; Schuitemaker H; Zahn R
    PLoS One; 2018; 13(2):e0192312. PubMed ID: 29462200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
    Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
    Geisbert TW; Strong JE; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S91-7. PubMed ID: 26063223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.
    Babirye P; Musubika C; Kirimunda S; Downing R; Lutwama JJ; Mbidde EK; Weyer J; Paweska JT; Joloba ML; Wayengera M
    BMC Infect Dis; 2018 Oct; 18(1):498. PubMed ID: 30285648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenicity of Ebola and Marburg Viruses Is Associated With Differential Activation of the Myeloid Compartment in Humanized Triple Knockout-Bone Marrow, Liver, and Thymus Mice.
    Lavender KJ; Williamson BN; Saturday G; Martellaro C; Griffin A; Hasenkrug KJ; Feldmann H; Prescott J
    J Infect Dis; 2018 Nov; 218(suppl_5):S409-S417. PubMed ID: 30085162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg viruses.
    Martines RB; Ng DL; Greer PW; Rollin PE; Zaki SR
    J Pathol; 2015 Jan; 235(2):153-74. PubMed ID: 25297522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional CD8+ T cell responses in lethal Ebola virus infection.
    Bradfute SB; Warfield KL; Bavari S
    J Immunol; 2008 Mar; 180(6):4058-66. PubMed ID: 18322215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
    Swenson DL; Wang D; Luo M; Warfield KL; Woraratanadharm J; Holman DH; Dong JY; Pratt WD
    Clin Vaccine Immunol; 2008 Mar; 15(3):460-7. PubMed ID: 18216185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors.
    Kuzmina NA; Younan P; Gilchuk P; Santos RI; Flyak AI; Ilinykh PA; Huang K; Lubaki NM; Ramanathan P; Crowe JE; Bukreyev A
    Cell Rep; 2018 Aug; 24(7):1802-1815.e5. PubMed ID: 30110637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-Mediated Virus Neutralization Is Not a Universal Mechanism of Marburg, Ebola, or Sosuga Virus Clearance in Egyptian Rousette Bats.
    Schuh AJ; Amman BR; Sealy TK; Kainulainen MH; Chakrabarti AK; Guerrero LW; Nichol ST; Albarino CG; Towner JS
    J Infect Dis; 2019 May; 219(11):1716-1721. PubMed ID: 30590775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for immunisation against Marburg and Ebola viruses.
    Geisbert TW; Bausch DG; Feldmann H
    Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections.
    Swenson DL; Warfield KL; Negley DL; Schmaljohn A; Aman MJ; Bavari S
    Vaccine; 2005 Apr; 23(23):3033-42. PubMed ID: 15811650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.
    Shedlock DJ; Aviles J; Talbott KT; Wong G; Wu SJ; Villarreal DO; Myles DJ; Croyle MA; Yan J; Kobinger GP; Weiner DB
    Mol Ther; 2013 Jul; 21(7):1432-44. PubMed ID: 23670573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses.
    Wang D; Schmaljohn AL; Raja NU; Trubey CM; Juompan LY; Luo M; Deitz SB; Yu H; Woraratanadharm J; Holman DH; Moore KM; Swain BM; Pratt WD; Dong JY
    Vaccine; 2006 Apr; 24(15):2975-86. PubMed ID: 16530297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.